High serum vascular endothelial growth factor level is an adverse prognostic factor for high‐risk diffuse large B‐cell lymphoma patients treated with dose‐dense chemoimmunotherapy
暂无分享,去创建一个
H. Holte | M. Eriksson | Ø. Fluge | M. Jerkeman | M. Björkholm | S. Leppä | L. Pedersen | H. Nurmi | Karin Rydström | Sari Riihijärvi | L. Pedersen